Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Cash from Financing Activities (2016 - 2022)

RedHill Biopharma has reported Cash from Financing Activities over the past 11 years, most recently at $14.9 million for Q2 2022.

  • Quarterly Cash from Financing Activities rose 943.24% to $14.9 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $26.5 million through Jun 2022, down 65.43% year-over-year, with the annual reading at $7.3 million for FY2025, 7.88% down from the prior year.
  • Cash from Financing Activities was $14.9 million for Q2 2022 at RedHill Biopharma, up from -$4.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $59.1 million in Q1 2020 and troughed at -$4.9 million in Q1 2022.
  • The 5-year median for Cash from Financing Activities is $7.9 million (2020), against an average of $14.4 million.
  • Year-over-year, Cash from Financing Activities surged 78406.67% in 2018 and then crashed 132.41% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at $18.4 million in 2018, then skyrocketed by 96.67% to $36.1 million in 2019, then tumbled by 78.0% to $7.9 million in 2020, then skyrocketed by 121.25% to $17.6 million in 2021, then dropped by 15.11% to $14.9 million in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Cash from Financing Activities are $14.9 million (Q2 2022), -$4.9 million (Q1 2022), and $17.6 million (Q4 2021).